Clinical Trial Update: Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3]) [Phase 2]

View source ↗

Summary

Phase 2 crossover study evaluating cholinergic target engagement for gait dysfunction in Parkinson's disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Michigan | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-01-27